159 related articles for article (PubMed ID: 38609987)
1. The effect of an anti-malarial herbal remedy, Maytenus senegalensis, on electrocardiograms of healthy Tanzanian volunteers.
Kassimu KR; Ali AM; Omolo JJ; Mdemu A; Machumi F; Ngasala B
Malar J; 2024 Apr; 23(1):103. PubMed ID: 38609987
[TBL] [Abstract][Full Text] [Related]
2. Safety and Tolerability of an Antimalarial Herbal Remedy in Healthy Volunteers: An Open-Label, Single-Arm, Dose-Escalation Study on
Kassimu K; Milando F; Omolo J; Mdemu A; Nyaulingo G; Mbarak H; Mohamed L; Rashid R; Ahmed S; Rashid M; Msami H; Damiano D; Simon B; Mbaga T; Issa F; Lweno O; Balige N; Hassan O; Mwalimu B; Hamad A; Olotu A; Mårtensson A; Machumi F; Jongo S; Ngasala B; Abdulla S
Trop Med Infect Dis; 2022 Nov; 7(12):. PubMed ID: 36548651
[TBL] [Abstract][Full Text] [Related]
3. In vivo antiplasmodial and toxicological effect of Maytenus senegalensis traditionally used in the treatment of malaria in Tanzania.
Malebo HM; Wiketye V; Katani SJ; Kitufe NA; Nyigo VA; Imeda CP; Ogondiek JW; Sunguruma R; Mhame PP; Massaga JJ; Mammuya B; Senkoro KP; Rumisha SF; Malecela MN; Kitua AY
Malar J; 2015 Feb; 14():79. PubMed ID: 25890324
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania.
Mhamilawa LE; Wikström S; Mmbando BP; Ngasala B; Mårtensson A
Malar J; 2020 Jul; 19(1):250. PubMed ID: 32664948
[TBL] [Abstract][Full Text] [Related]
6. Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms.
Kabanywanyi AM; Baiden R; Ali AM; Mahende MK; Ogutu BR; Oduro A; Tinto H; Gyapong M; Sie A; Sevene E; Macete E; Owusu-Agyei S; Adjei A; Compaoré G; Valea I; Osei I; Yawson A; Adjuik M; Akparibo R; Kakolwa MA; Abdulla S; Binka F
PLoS One; 2016; 11(10):e0164851. PubMed ID: 27764178
[TBL] [Abstract][Full Text] [Related]
7. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania.
Baiden R; Oduro A; Halidou T; Gyapong M; Sie A; Macete E; Abdulla S; Owusu-Agyei S; Mulokozi A; Adjei A; Sevene E; Compaoré G; Valea I; Osei I; Yawson A; Adjuik M; Akparibo R; Ogutu B; Upunda GL; Smith P; Binka F
Malar J; 2015 Apr; 14():160. PubMed ID: 25885858
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.
Manning J; Vanachayangkul P; Lon C; Spring M; So M; Sea D; Se Y; Somethy S; Phann ST; Chann S; Sriwichai S; Buathong N; Kuntawunginn W; Mitprasat M; Siripokasupkul R; Teja-Isavadharm P; Soh E; Timmermans A; Lanteri C; Kaewkungwal J; Auayporn M; Tang D; Chour CM; Prom S; Haigney M; Cantilena L; Saunders D
Antimicrob Agents Chemother; 2014 Oct; 58(10):6056-67. PubMed ID: 25092702
[TBL] [Abstract][Full Text] [Related]
9. Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study.
McCarthy JS; Yalkinoglu Ö; Odedra A; Webster R; Oeuvray C; Tappert A; Bezuidenhout D; Giddins MJ; Dhingra SK; Fidock DA; Marquart L; Webb L; Yin X; Khandelwal A; Bagchus WM
Lancet Infect Dis; 2021 Dec; 21(12):1713-1724. PubMed ID: 34715032
[TBL] [Abstract][Full Text] [Related]
10. Antiplasmodial potential of traditional antimalarial phytotherapy remedies used by the Kwale community of the Kenyan Coast.
Muthaura CN; Keriko JM; Mutai C; Yenesew A; Gathirwa JW; Irungu BN; Nyangacha R; Mungai GM; Derese S
J Ethnopharmacol; 2015 Jul; 170():148-57. PubMed ID: 26002768
[TBL] [Abstract][Full Text] [Related]
11. Phytochemical screening, antioxidant analyses, and in vitro and in vivo antimalarial activities of herbal medicinal plant - Rotheca serrata (L.) Steane & Mabb.
Chanu WK; Chatterjee A; Singh N; Nagaraj VA; Singh CB
J Ethnopharmacol; 2024 Mar; 321():117466. PubMed ID: 37981115
[TBL] [Abstract][Full Text] [Related]
12. Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.
Millat-Martínez P; Ila R; Laman M; Robinson L; Karunajeewa H; Abel H; Pulai K; Sanz S; Manning L; Moore B; Bassat Q; Mitjà O
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249696
[TBL] [Abstract][Full Text] [Related]
13. High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania.
Mandara CI; Francis F; Chiduo MG; Ngasala B; Mandike R; Mkude S; Chacky F; Molteni F; Njau R; Mohamed A; Warsame M; Ishengoma DS
Malar J; 2019 Mar; 18(1):99. PubMed ID: 30909922
[TBL] [Abstract][Full Text] [Related]
14. Antiplasmodial, antimalarial activities and toxicity of African medicinal plants: a systematic review of literature.
Tajbakhsh E; Kwenti TE; Kheyri P; Nezaratizade S; Lindsay DS; Khamesipour F
Malar J; 2021 Aug; 20(1):349. PubMed ID: 34433465
[TBL] [Abstract][Full Text] [Related]
15. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
Watts RE; Odedra A; Marquart L; Webb L; Abd-Rahman AN; Cascales L; Chalon S; Rebelo M; Pava Z; Collins KA; Pasay C; Chen N; Peatey CL; Möhrle JJ; McCarthy JS
PLoS Med; 2020 Aug; 17(8):e1003203. PubMed ID: 32822347
[TBL] [Abstract][Full Text] [Related]
16. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
17. Piperaquine Pharmacokinetic and Pharmacodynamic Profiles in Healthy Volunteers of Papua New Guinea after Administration of Three-Monthly Doses of Dihydroartemisinin-Piperaquine.
Millat-Martínez P; Salman S; Moore BR; Baro B; Page-Sharp M; Batty KT; Robinson LJ; Pomat W; Karunajeewa H; Laman M; Manning L; Mitjà O; Bassat Q
Antimicrob Agents Chemother; 2022 Aug; 66(8):e0018522. PubMed ID: 35862743
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of aqueous extract from Maytenus senegalensis (Lam.) Exell stem bark on egg hatching, larval migration and adult worms of Haemonchus contortus.
Zangueu CB; Olounlade AP; Ossokomack M; Djouatsa YNN; Alowanou GG; Azebaze AGB; Llorent-Martínez EJ; de Córdova MLF; Dongmo AB; Hounzangbe-Adote MS
BMC Vet Res; 2018 May; 14(1):147. PubMed ID: 29716590
[TBL] [Abstract][Full Text] [Related]
19. In vivo anti-inflammatory effect and toxicological screening of Maytenus heterophylla and Maytenus senegalensis extracts.
da Silva G; Taniça M; Rocha J; Serrano R; Gomes ET; Sepodes B; Silva O
Hum Exp Toxicol; 2011 Jul; 30(7):693-700. PubMed ID: 20670987
[TBL] [Abstract][Full Text] [Related]
20. Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults.
Hanboonkunupakarn B; van der Pluijm RW; Hoglund R; Pukrittayakamee S; Winterberg M; Mukaka M; Waithira N; Chotivanich K; Singhasivanon P; White NJ; Dondorp AM; Tarning J; Jittamala P
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
